These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 19849977)

  • 1. [P53, ARF and P16: the last defence against reprogrammation].
    Dijon-Grinand M; De Vos J
    Med Sci (Paris); 2009 Oct; 25(10):793-4. PubMed ID: 19849977
    [No Abstract]   [Full Text] [Related]  

  • 2. The INK4a/ARF network in tumour suppression.
    Sherr CJ
    Nat Rev Mol Cell Biol; 2001 Oct; 2(10):731-7. PubMed ID: 11584300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human tumor suppressor ARF impedes S-phase progression independent of p53.
    Yarbrough WG; Bessho M; Zanation A; Bisi JE; Xiong Y
    Cancer Res; 2002 Feb; 62(4):1171-7. PubMed ID: 11861400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p16INK4a modulates p53 in primary human mammary epithelial cells.
    Zhang J; Pickering CR; Holst CR; Gauthier ML; Tlsty TD
    Cancer Res; 2006 Nov; 66(21):10325-31. PubMed ID: 17079452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p16 and ARF: activation of teenage proteins in old age.
    Satyanarayana A; Rudolph KL
    J Clin Invest; 2004 Nov; 114(9):1237-40. PubMed ID: 15520854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
    Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis.
    Ruddell A; Kelly-Spratt KS; Furuya M; Parghi SS; Kemp CJ
    Oncogene; 2008 May; 27(22):3145-55. PubMed ID: 18059331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
    Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
    Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 and tumor suppression.
    Van Dyke T
    N Engl J Med; 2007 Jan; 356(1):79-81. PubMed ID: 17202460
    [No Abstract]   [Full Text] [Related]  

  • 10. Co-transfection of p16(INK4a) and p53 genes into the K562 cell line inhibits cell proliferation.
    Rui HB; Su JZ
    Haematologica; 2002 Feb; 87(2):136-42. PubMed ID: 11836163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitination of, and sumoylation by, the Arf tumor suppressor.
    den Besten W; Kuo ML; Tago K; Williams RT; Sherr CJ
    Isr Med Assoc J; 2006 Apr; 8(4):249-51. PubMed ID: 16671360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
    D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG
    Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenes in tumors of gallbladder and biliary tract.
    Enjoji M; Nakamuta M; Nawata H
    Fukuoka Igaku Zasshi; 2004 Feb; 95(2):31-5. PubMed ID: 15101197
    [No Abstract]   [Full Text] [Related]  

  • 14. p16(INK4a) and p53 deficiency cooperate in tumorigenesis.
    Sharpless NE; Alson S; Chan S; Silver DP; Castrillon DH; DePinho RA
    Cancer Res; 2002 May; 62(10):2761-5. PubMed ID: 12019151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
    D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
    Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell research. Recipe for induced pluripotent stem cells just got clearer.
    Normile D
    Science; 2009 Aug; 325(5942):803. PubMed ID: 19679782
    [No Abstract]   [Full Text] [Related]  

  • 17. Arf and p53 act as guardians of a quiescent cellular state by protecting against immortalization of cells with stable genomes.
    Osawa T; Atsumi Y; Sugihara E; Saya H; Kanno M; Tashiro F; Masutani M; Yoshioka K
    Biochem Biophys Res Commun; 2013 Mar; 432(1):34-9. PubMed ID: 23376716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell cycle control and cancer.
    Sherr CJ
    Harvey Lect; 2000-2001; 96():73-92. PubMed ID: 12200872
    [No Abstract]   [Full Text] [Related]  

  • 19. Potent p53-independent tumor suppressor activity of ARF in melanoma-genesis.
    Widlund HR; Fisher DE
    Pigment Cell Res; 2007 Oct; 20(5):339-40. PubMed ID: 17850505
    [No Abstract]   [Full Text] [Related]  

  • 20. The Arf/p53 pathway in cancer and aging.
    Matheu A; Maraver A; Serrano M
    Cancer Res; 2008 Aug; 68(15):6031-4. PubMed ID: 18676821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.